The purpose of this study is to assess the efficacy of abatacept after subcutaneous administration and intravenous administration in Japanese active rheumatoid arthritis (RA) subjects with inadequate response to methotrexate (MTX), and on background MTX in the short term.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01001832?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
